drugset / Trial / NCT05476991

Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis

NCT05476991

Phase 3 Recruiting 2800 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedFactorialOpen-labelTreatment

Summary

REDUCING INFLAMMATION IN ISCHEMIC STROKE WITH COLCHICINE, AND TICAGRELOR IN HIGH-RISK PATIENTS-EXTENDED TREATMENT IN ISCHEMIC STROKE.

Timeline

Start
2023-05-17
Primary completion
2027-09-01
Completion
2027-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 75 mg
Subject Aspirin Small molecule 300 mg
Subject Colchicine Small molecule 0.5 mg
Subject Ticagrelor Small molecule 90 mg